Table 1 Baseline characteristics of included patients
Total (n = 592) | FFR-PCI (n = 207) | Angiography-PCI (n = 385) | |
|---|---|---|---|
Age (years) | 63.91 ± 12.15 | 65.13 ± 12.74 | 63.26 ± 11.77 |
Gender | |||
Male | 416 (70.3) | 152 (73.4) | 264 (68.6) |
Female | 176 (29.7) | 55 (26.6) | 121 (31.4) |
Medical history | |||
Hypertension | 298 (50.3) | 113 (54.6) | 185 (48.1) |
Diabetes | 142 (24.0) | 53 (25.6) | 89 (23.1) |
Hyperlipidemia | 49 (8.3) | 17 (8.2) | 32 (8.3) |
Previous MI | 40 (6.8) | 9 (4.3) | 31 (8.1) |
Previous PCI/CABG | 42 (7.1) | 13 (6.3) | 29 (7.5) |
Current smokers | 378 (63.9) | 127 (61.4) | 251 (65.2) |
Body mass index | 24.50 ± 3.58 | 24.93 ± 3.85 | 24.27 ± 3.41 |
Medicines | |||
Aspirin | 570 (96.3) | 201 (97.1) | 369 (95.8) |
Clopidogrel | 592 (100) | 207 (100) | 385 (100) |
Statin | 592 (100) | 207 (100) | 385 (100) |
β-Blocker | 289 (48.8) | 98 (47.3) | 191 (49.6) |
ACEI/ARB | 256 (43.2) | 87 (42.0) | 169 (43.9) |
Echocardiography | |||
Ejection fraction (%) | 43.38 ± 6.29 | 43.56 ± 6.31 | 43.29 ± 6.27 |
LVEDd (cm) | 5.44 ± 0.44 | 5.47 ± 0.41 | 5.42 ± 0.45 |